Skip to main content
. Author manuscript; available in PMC: 2014 Jul 21.
Published in final edited form as: Cancer Biol Ther. 2007 Oct 19;7(1):135–144. doi: 10.4161/cbt.7.1.5199

Table 3.

52 candidate genes (58 SNPs) exhibiting extreme (θ ≥ 2) ASE in familial pancreatic cancer (NFPTR) samples

Heterozygous NFPTR individuals
Gene Locus RefSNP MAF SNP Function Class± Tested # extreme
ASE
% extreme
ASE
Extreme
θ
Background
θ
Nonsynonymous SNPs
MUTYH 1p34.3-p32.1 rs3219484 0.1 198G>A 22Val>Met a 12 1 8 3 1.58
TNFRSF1B 1p36.3-p36.2 rs1061622 0.26 676T>G 196Met>Arg b 36 2 6 2.4 1.53
EPHX1 1q42.1 rs1051740 0.32 612T>C 113Tyr>His b 34 1 3 2.07 1.41
CASP8 2q33-q34 rs1045485 0.13 1192G>C 302Asp>His b 8 1 13 2.63 1.68
BARD1 (1)* 2q34-q35 rs2229571 0.4 1207G>C 378Arg>Ser b 42 1 2 2.27 1.37
PTCH1 (2) 9q22.3 rs357564 0.33 4132C>T 1315Pro>Leu b 9 3 33 2.98 2.12
ZWINT 10q21-q22 rs2241666 0.38 596A>G 187Arg>Gly b 38 1 3 4 1.51
BAG3 10q25.2-q26.2 rs2234962 0.21 757T>C 151Cys>Arg a 3 1 33 2.26 1.72
GSTP1 11q13 rs947894 0.34 342A>G 105Ile>Val a 42 1 2 2.44 1.38
MMP7 11q21-q22 rs10502001 0.2 277G>A 77Arg>His b 31 2 6 2.32 1.51
FLT3 13q12 rs1933437 0.36 738C>T 227Thr>Met a 24 1 4 2.07 1.61
BRCA2 (3) 13q12.3 rs144848 0.33 1341A>C 372Asn>His a 46 1 2 2.33 2.33
TEP1 14q11.2 rs1760904 0.49 3624T>C 1195Ser>Pro b 43 1 2 2.52 1.31
CARD15 (4) 16q12 rs2066842 0.28 907C>T 268Pro>Ser a 40 1 3 5.79 1.83
FANCA 16q24.3 rs2239359 0.37 1543G>A 501Gly>Ser b 49 3 6 2.38 1.56
PLAUR 19q13 rs2302524 0.17 889A>G 220Lys>Arg b 25
482
2
23
8
5
2.32
2.74 (6.7)‡
1.58
1.63 (3.1)
Synonymous SNPs
FRAP1 (5) 1p36.2 rs11121705 0.3 1516T>C 479Asp b 42 4 10 2.57 1.57
FRAP1 (5) 1p36.2 rs1057079 0.27 4810G>A 1577Ala b 34 3 9 2.57 1.54
DST 6p12-p11 rs2230862 0.5 4176G>A 1358Lys a 54 1 2 2.37 1.17
DDR1 6p21.3 rs1049623 0.19 2130T>C 599Val b 55 2 4 2.14 1.42
MET 7q31 rs41736 0.4 4045C>T 1286Asp a 16 1 6 2.1 1.49
EPHA1 7q34 rs10952549 0.21 1924C>T 613Leu a 5 1 20 2.39 2.1
PTK2B 8p22-p11.2 rs1030526 0.4 978G>A 110Thr b 38 1 3 2.19 1.37
TEK 9p21 rs639225 0.48 2110A>G 654Ser a 17 1 6 2.16 1.36
PTCH1 (2) 9q22.3 rs2066836 0.22 1874C>T 562Ala b 39 3 8 2.67 1.68
CYP2E1 10q24.3-qter rs2515641 0.13 1296T>C 421Phe b 17 1 6 2.33 1.96
PDE1B 12q13 rs1249950 0.45 1642T>C 492Asn a 46 1 2 2.06 1.44
BRCA2 (3) 13q12.3 rs1799955 0.21 7469A>G 2414Ser b 32 1 3 2.8 1.57
TCF4 18q21.1 rs6567211 0.39 2123G>A 643Ser b 42 1 2 4.92 4.92
MAP3K9 14q24.3-q31 rs3829955 0.17 2676C>T 892Asn a 32 1 3 3.08 1.52
CARD15 (4) 16q12 rs2066843 0.28 1482C>T 459Arg a 41 2 5 3.16 2
CDH1 16q22.1 rs1801552 0.41 2200T>C 692Ala b 27 2 7 2.91 1.74
TOB1 17q21 rs4626 0.29 992A>G 319Lys b 41 1 2 2.06 1.24
RIPK4 21q22.3 rs3746893 0.38 1524G>A 492Ala b 9
587
2
29
22
5
4.18
2.70 (6.5)‡
2.35
1.80 (3.5)‡
Untranslated region SNPs
BARD1 (1) 2q34-q35 rs1129804 0.31 44C>G exon1 b 46 6 13 2.21 1.64
COL4A3 2q36-q37 rs2070735 0.14 5490C>A exon52 a 16 1 6 2.78 1.7
FANCD2 3p25.3 rs7647987 0.21 4556G>A intron43 b 29 1 3 2.06 1.37
TNFSF10 3q26 rs1131542 0.34 1297C>A exon5 b 49 1 2 2.77 1.58
SPARC 5q31.3-q32 rs1059829 0.47 2120T>C exon10 b 54 2 4 2.14 1.46
FRK 6q21-q22.3 rs495565 0.38 2566G>A exon8 b 46 1 2 2.56 1.41
SLC22A2 6q26 rs3127594 0.13 2198T>A exon11 a 9 3 33 2.45 2.02
SERPINE1 7q21.3-q22 rs1050813 0.23 2176G>A exon9 a 28 2 7 2.11 1.6
Untranslated region SNPs
SMO 7q32.3 rs1061285 0.13 3660C>A exon12 b 18 1 6 2.32 1.5
NBN 8q21 rs1063045 0.31 212T>C exon2 b 42 1 2 3.07 3.07
NOTCH1 9q34.3 rs6563 0.48 9010G>A exon34 b 46 1 2 2.4 1.55
DNMT2 10p15.1 rs10904889 0.16 2082G>T exon11 b 19 3 16 2.23 1.64
CCKBR 11p15.4 rs1042048 0.33 1974G>A exon5 a 6 2 33 2.3 2
LRRC32 11q13.5-q14 rs3781701 0.32 3312T>C exon34 a 17 1 6 2.26 1.47
MMP1 11q22.3 rs5854 0.33 1750T>C exon10 a 16 1 6 2.13 1.4
KRAS(6) 12p12.1 rs13096 0.5 3636G>A exon5 b 47 1 2 2.31 1.4
KRAS(6) 12p12.1 rs1801539 0.5 4534G>A exon5 b 49 1 2 2.14 2.14
HDAC7A 12q13.1 rs9859 0.21 3798C>A exon24 b 31 1 3 3.64 1.49
THBS1 15q15 rs1051442 0.15 3771T>C exon22 b 9 1 11 2.32 1.73
LRRK1 15q26.3 rs1048326 0.14 4704T>C exon20 b 28 1 4 2.36 1.52
IMPACT 18q11.2-q12.1 rs1053474 0.33 3452G>A exon11 b 40 1 3 2.41 1.37
GNG7 19p13.3 rs3752174 0.26 808T>C exon5 b 39 1 3 2.14 1.45
JAG1 20p12 rs7828 0.36 5201T>G exon26 b 48 1 2 2.22 1.64
TFF2 21q22.3 rs225334 0.4 513G>A exon4 b 12
744
1
36
8
5
2.13
2.39 (5.3)‡
1.45
1.65 (3.1)
*

Numbers in parentheses identify SNPs marking the same gene.

±

Class a/b identifies SNPs showing ASE exclusively in NFPTR and those common to CEPH and NFPTR, respectively.

The extreme and background θ are calculated from those showing ASE and all heterozygotes, respectively.

Values in parentheses represent average fold change calculated from the average θ.